Increased expression of peripheral benzodiazepine receptors and diazepam binding inhibitor in human tumors sited in the liver.

The peripheral benzodiazepine receptor system triggers intracellular metabolic events and has been associated with cell proliferation. Its endogenous ligand, the diazepam binding inhibitor, contributes to steroidogenesis by promoting cholesterol delivery to the inner mitochondrial membrane. The present study was undertaken to verify whether this system is altered in tumors sited in the liver. Peripheral benzodiazepine receptors and diazepam binding inhibitor were studied using immunocytochemistry and in situ hybridization in 9 human tumors sited in the liver, in liver hyperplasia, cirrhotic nodular regeneration, intestinal adenocarcinoma and in surrounding non-tumoral tissue. Immunocytochemical staining and in situ hybridization demonstrated that peripheral benzodiazepine receptors and diazepam binding inhibitor were more prominently expressed in neoplastic cells than in non-tumoral tissue. They were present in the same cells, suggesting that diazepam binding inhibitor may act in an intracrine manner in these cells. Higher peripheral benzodiazepine receptors and diazepam binding inhibitor expression in tumor cells suggest an implication of this system in the metabolism of neoplastic cells. Furthermore the evaluation of peripheral benzodiazepine receptor and diazepam binding inhibitor expression might be useful in evaluating malignancy and in diagnostic approaches of tumors in liver tissue.

[1]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. , 1990, The Journal of biological chemistry.

[2]  V. Papadopoulos,et al.  Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex , 1992, Molecular and Cellular Endocrinology.

[3]  Hannu,et al.  Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. , 1993, The American journal of pathology.

[4]  M. Gavish,et al.  Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor , 1992, Journal of neurochemistry.

[5]  Imaging of brain tumors using peripheral benzodiazepine receptor ligands. , 1989, Journal of neurosurgery.

[6]  A. Guidotti,et al.  Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. , 1991, Life sciences.

[7]  M. Baraldi,et al.  Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. , 1998, Life sciences.

[8]  L. Andersson,et al.  Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar separation , 1981, Nature.

[9]  J. Kononen,et al.  Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. , 1995, Cancer research.

[10]  I. Appollonio,et al.  Benzodiazepine receptors and diazepam‐binding inhibitor in human cerebral tumors , 1989, Annals of neurology.

[11]  J. Tallman,et al.  The GABA-ergic system: a locus of benzodiazepine action. , 1985, Annual review of neuroscience.

[12]  A. Guidotti,et al.  Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. , 1988, Molecular pharmacology.

[13]  A. Guidotti,et al.  1,4-Benzodiazepines and gamma-aminobutyric acid: pharmacological and biochemical correlates. , 1979, Pharmacology.

[14]  G. Clarke,et al.  Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells , 1980, Nature.

[15]  H. Alho,et al.  Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[17]  Carlo Ferrarese,et al.  Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma , 1998, Regulatory Peptides.

[18]  B. Martin,et al.  Purification of a novel DBI processing product, DBI39–75, and characterization of its binding site in rat brain , 1994, Regulatory Peptides.

[19]  M. Pawlikowski,et al.  Effects of diazepam on cell proliferation in cerebral cortex, anterior pituitary and thymus of developing rats. , 1987, Life sciences.

[20]  R. van Hillegersberg,et al.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. , 1992, Gastroenterology.

[21]  P. Casellas,et al.  Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. , 1996, Blood.

[22]  M. Gavish,et al.  Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. , 1990, Clinical science.

[23]  D. Williams,et al.  Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. , 1996, Biochemical pharmacology.

[24]  Leon Schiff,et al.  Diseases of the liver , 1975 .

[25]  H. Alho,et al.  The transcriptional and translational control of diazepam binding inhibitor expression in rat male germ-line cells. , 1997, DNA and cell biology.